Emerging small-molecule AKR1C3 inhibitors development for cancer therapy: Progress from 2021 to 2025. - Gao HN; Wu XS; Pan ZJ; Liu HM; Chen KQ; Teng MX; Zhao JT; Zhou J; You QD; Zhang C (European journal of medicinal chemistry, 2026)